HHS Privacy Rule Will Close “Loophole” On Drug Marketing To Patients
Executive Summary
HHS' final privacy regulations will close a loophole that would have allowed pharmaceutical companies to obtain protected patient information from healthcare providers for purposes of marketing products directly to patients